ArticleJournal of rheumatic diseases2022

Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study.

Jina Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.